blank
blank

Slovenia joins ERDERA’s Joint Transnational Call for Proposals on Rare Disease Therapies

blank

We are delighted to announce that the Ministry of Health of the Republic of Slovenia (Ministrstvo za zdravje) has officially joined the funding organisations participating in the first Joint Transnational Call for Proposals on Rare Disease Therapies. This initiative is part of ERDERA’s ongoing commitment to advancing cutting-edge research in this critical area.

This collaboration represents a major milestone in strengthening international cooperation to address rare diseases through innovative therapeutic approaches. It also highlights an important advancement in promoting greater inclusion and participation of countries that have been underrepresented in funding calls, paving the way for more equitable research opportunities.

Updated call documents now available

We are pleased to announce that the updated documents for the JTC 2025 are now accessible on our website. These documents provide detailed information on eligibility, application guidelines, and evaluation criteria, ensuring a smooth and informed proposal submission process.

Key updates (as of 16 January 2025):

  • Call text: addition of Ministry of Health of the Republic of Slovenia (SI MoH), Slovenia, to funding organisations participating in the call and to underrepresented countries list.
  • Guidelines: changes in national guidelines for FCT, CIHR, RCN, BMBF, multinational PAO funding; addition of national guidelines for SI MoH, Slovenia.
  • Pre-proposal submission preview: removal of budget justification entries.
  • FAQ: additional Q&A.

For further details, access the updated call documents here.

Application timeline

The JTC 2025 will follow a two-stage submission process:

  • 13 February 2025: Pre-proposal submission deadline.
  • 9 July 2025: Full proposals submission deadline. Funding decisions are expected by December 2025.

Contact and stay updated

For more information, contact the Joint Call Secretariat at SelteneErkrankungen@dlr.de or reach out to the relevant national contact point.

Stay informed with the latest updates from ERDERA by regularly visiting our website, subscribing to our newsletter, and following us on social media.

News & Updates

You might also be interested in

Bojana Mirosavljevic

“Patients are the glue that keeps all other stakeholders together—without them, the system simply does not exist”

ERDERA interviews Bojana Mirosavljevic, scientist and founder of the Život/Life association in Serbia; and one of the country’s leading voices rare disease patient advocacy.
Radka Kaneva and Petia Stratieva, Sofia, March 2026

“National Mirror Groups are essentially a bridge — bringing European developments, standards and opportunities to clinicians and researchers.”

ERDERA interviews Prof. Radka Kaneva and Dr Petia Stratieva, two leading members of Bulgaria’s National Mirror Group (NMG), to explore how the country is working to align its rare disease ecosystem with European developments.
Gdańsk - Medical University of Gdańsk

From Hyderabad to Gdansk: collaborative diagnostic efforts that bridge research and clinical practice to shorten patients’ path to answers

ERDERA joins the Wilhelm Foundation and the Gdansk Medical University and Clinical Centre to strengthen phenotype‑led diagnosis for people living with undiagnosed conditions
NMGs Sofia

Countries step up joint approaches to rare disease research at first in person ERDERA National Alignment Board meeting

Taking place at a pivotal moment – with the European Rare Disease Plan expected to move forward significantly during 2026 – the meetings brought together National Mirror Group (NMG) representatives from Europe and beyond, alongside European Commission stakeholders, IRDiRC and international partners.

ERDERA's

search form